Accretion Pharmaceuticals Limited, established in 2012, produces and sells tablets, capsules, and healthcare products, offering both generic and branded formulations. It provides contract manufacturing services for domestic and international clients, including government and private institutions.
The company's board approved expanding its business scope in pharmaceuticals and healthcare. It also seeks to increase borrowing limits and enhance flexibility for loans, guarantees, and investments. These strategic moves, aimed at future growth, require shareholder approval via postal ballot.